Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.

Styler, M J

Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis. [electronic resource] - Bone marrow transplantation Jul 1996 - 171-6 p. digital

Publication Type: Journal Article; Multicenter Study

0268-3369


Adolescent
Adult
Aged
Anti-Bacterial Agents--adverse effects
Bone Marrow Transplantation
Busulfan--adverse effects
Child
Child, Preschool
Ciprofloxacin--adverse effects
Cyclophosphamide--adverse effects
Estrogens--adverse effects
Female
Genetic Diseases, Inborn--therapy
Graft vs Host Disease--prevention & control
Hepatic Veno-Occlusive Disease--chemically induced
Humans
Immunosuppressive Agents--adverse effects
Incidence
Life Tables
Liver Diseases--complications
Liver Function Tests
Male
Methotrexate--adverse effects
Middle Aged
Multiple Organ Failure--chemically induced
Multivariate Analysis
Neoplasms--therapy
Progestins--adverse effects
Retrospective Studies
Risk Factors
Transplantation Conditioning--adverse effects
Vancomycin--adverse effects